Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Gyrd-Hansen, M. et al. IAPs: from caspase inhibitors to modulators of NF-kB, inflammation and cancer. Nat. Rev. Cancer 10, 561–574 (2010).
Fulda, S. et al. Targeting IAP proteins for therapeutic intervention in cancer. Nat. Rev. Drug Discov. 11, 109–123 (2012).
Nakamura, N. et al. Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin. Mol. Cell. Proteomics 11, M111.013243 (2012).
Nakahara, T. et al. YM155, a novel small-molecule survivin suppressant, induces regression of established human hormon-refractory prostate tumor xenografts. Cancer Res. 67, 8014–8021 (2007).
Cai, Q. et al. A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. J. Med. Chem. 28, 2714–2726 (2011).
LaCasse, E. C. Pulling the plug on a cancer cell by eliminating XIAP with AEG35156. Cancer Lett. 332, 215–224 (2013).
Hayakawa, Y. et al. Adenopeptin, a new apoptosis inducer in transformed cells from Chrysosporium sp. Tetrahedoron 54, 15871–15878 (1998).
Fukushima, K. et al. Studies of antibiotics, leucinostatins. J. Antibiot. 36, 1606–1630 (1983).
Bruckner, H. et al. Aib and Iva in the biosphere: neither rare nor necessarily extraterrestrial. Chem. Biodivers. 6, 38–56 (2009).
Fujii, K. et al. A nonempirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a peptide: elucidation of limitations of Marfey’s method and of its separation mechanism. Anal. Chem. 69, 3346–3352 (1997).
Fortugno, P. et al. Regulation of survivin function by Hsp90. Proc. Natl Acad. Sci. USA. 100, 13791–13796 (2003).
Papathanassiu, A. E. et al. F1F0-ATP synthase functions as a co-chaperone of Hsp90-substrate protein complexes. Biochem. Biophys. Res. Commun. 345, 419–429 (2006).
Adonia, E. et al. Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo. Cell Stress Chaperones 16, 181–193 (2011).
Cross, R. L. & Kohlbrenner, W. E. The mode of inhibition of oxidative phosphorylation by efrapeptin (A23871). J. Biol. Chem. 253, 4865–4873 (1978).
Abrahams, J. P. et al. The structure of bovine F1-ATPase complexed with the peptide antibiotic efrapeptin. Proc. Natl Acad. Sci. USA 93, 9420–9424 (1996).
Acknowledgements
We thank Mr S Ohba for measurement of NMR spectrum.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on The Journal of Antibiotics website
Supplementary information
Rights and permissions
About this article
Cite this article
Iijima, M., Amemiya, M., Sawa, R. et al. Acremopeptin, a new peptaibol from Acremonium sp. PF1450. J Antibiot 70, 791–794 (2017). https://doi.org/10.1038/ja.2017.15
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2017.15
This article is cited by
-
Two new adenopeptins B and C inhibit sphere formation of pancreatic cancer cells
The Journal of Antibiotics (2024)
-
A new linear peptide, higapeptin, isolated from the mud flat-derived fungus Acremonium persicinum inhibits mitochondrial energy metabolism
Journal of Natural Medicines (2024)
-
Acremotins A–D, peptaibiotics produced by the soil-derived fungus Acremonium persicinum SC0105
The Journal of Antibiotics (2018)